摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-azidophenyl)imidazo[2,1-b]benzothiazole | 1388790-17-7

中文名称
——
中文别名
——
英文名称
2-(4-azidophenyl)imidazo[2,1-b]benzothiazole
英文别名
——
2-(4-azidophenyl)imidazo[2,1-b]benzothiazole化学式
CAS
1388790-17-7
化学式
C15H9N5S
mdl
——
分子量
291.336
InChiKey
GSTVSMVSVLIEHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.16
  • 重原子数:
    21.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66.06
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    2-(4-azidophenyl)imidazo[2,1-b]benzothiazoleN-(1-phenylbut-3-yn-2-yl)-2-[3,5-bis(trifluoromethyl)phenyl]acetamidecopper(ll) sulfate pentahydratesodium ascorbate 作用下, 以 四氢呋喃 为溶剂, 反应 6.0h, 以68%的产率得到N-[1-(1-(4-(imidazo(2,1-b)benzothiazol-2-yl)phenyl-1H-1,2,3-triazol-4-yl)-2-phenylethyl)]-2-[3,5-bis(trifluoromethyl)phenyl]acetamide
    参考文献:
    名称:
    ‘Click’ synthesis of a triazole-based inhibitor of Met functions in cancer cells
    摘要:
    The use of Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition permitted the synthesis of a new compound that is able to inhibit the HGF-induced scattering of MDCK (epithelial cells) and in vitro tumorigenesis of H1437 (non-small-cell lung cancer) and GTL-16 (human gastric carcinoma). In agreement with biochemical and biological results, docking studies within the ATP binding site of Met suggested for the new synthesized compound a binding mode similar to that of the active compound Triflorcas previously reported. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.05.078
  • 作为产物:
    描述:
    4-(benzo[d]imidazo[2,1-b]thiazol-2-yl)aniline硫酸 、 sodium nitrite 、 sodium azide 作用下, 以 为溶剂, 反应 0.58h, 以78%的产率得到2-(4-azidophenyl)imidazo[2,1-b]benzothiazole
    参考文献:
    名称:
    ‘Click’ synthesis of a triazole-based inhibitor of Met functions in cancer cells
    摘要:
    The use of Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition permitted the synthesis of a new compound that is able to inhibit the HGF-induced scattering of MDCK (epithelial cells) and in vitro tumorigenesis of H1437 (non-small-cell lung cancer) and GTL-16 (human gastric carcinoma). In agreement with biochemical and biological results, docking studies within the ATP binding site of Met suggested for the new synthesized compound a binding mode similar to that of the active compound Triflorcas previously reported. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.05.078
点击查看最新优质反应信息